New Report Pegs U.S. CBD Retail Sales at $10 billion by 2024
Palm Beach, FL – October 22, 2019 – CBD retail sales just in the U.S. are expected to pass $1 billion – a 133% jump year over year, as noted by the 2019 Hemp & CBD Industry Factbook. By 2024, sales could balloon to $10 billion. “The recent surge of consumer demand for CBD, coupled […]
Clinical Trials for Acute Myeloid Leukemia (AML) Drug Therapy Advancing with Encouraging Results
Palm Beach, FL –October 22, 2019 – There is much research activity in the acute myeloid leukemia (AML) the sector. The American Cancer Society’s (ACS) estimates for leukemia in the United States for 2019 predict that there will be 61,780 new cases of leukemia (all kinds) and 22,840 deaths from leukemia (all kinds) and about […]
Moleculin Increases Annamycin Production Due to Positive Clinical Trial Activity and Expanded Potential Indications
Expansion of potential indications includes lung-localized tumors Houston, TX – October 22, 2019 – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced the expansion of Annamycin production commitments in response to management’s assessment of positive […]
Tainted Cannabis and Vaping Illnesses Push Consumers Towards Premium Organic Products
FN Media Group Presents Potstocknews.com Market Commentary New York, NY – October 22, 2019 – Ongoing news about tainted cannabis and vaping-related illnesses has put the spotlight on the quality of cannabis products on the market and many consumers are looking to get their hands on premium pot for better quality and taste. But, […]
